Align Technology, Inc. ALGN | NASDAQ

$177.32 $0.58 | 0.33%

Company Overview:

Market Cap: $12.98B
PE Ratio: 32.24
52-Week Range: $141.74 - $295.69

10 Year Performance Metrics:

Total Return (with DRIP): 192.86% (11.34% / yr)
Total Return (no DRIP): 192.86% (11.34% / yr)
Share Price: 192.86%
ALGN Total Return
1Y 2Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

ALGN Earnings, Revenue, Cash & Debt, Shares Outstaning:

ALGN - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
ALGN - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
ALGN - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
ALGN - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
ALGN - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
ALGN - Cash & Debt
14-Day FREE Trial Get Full Access Now!
ALGN - Revenue
14-Day FREE Trial Get Full Access Now!
ALGN Revenue CAGR:1Y: 4.02%2Y: 5.07%5Y: 8.90%10Y: 17.49%
ALGN - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
ALGN EPS CAGR:1Y: -15.24%2Y: 60.44%5Y: -1.90%10Y: 11.22%
ALGN - Net Income
14-Day FREE Trial Get Full Access Now!
ALGN Net Income CAGR:1Y: -16.29%2Y: 57.64%5Y: -3.06%10Y: 10.13%
ALGN - EBITDA
14-Day FREE Trial Get Full Access Now!
ALGN EBITDA CAGR:1Y: -30.11%2Y: 3.12%5Y: -0.94%10Y: 9.94%
ALGN - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
ALGN Free Cash Flow CAGR:1Y: 1,851.33%2Y: 69.57%5Y: 8.42%10Y: 15.10%
ALGN - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
ALGN Free Cash Flow / Share CAGR:1Y: 1,885.00%2Y: 73.09%5Y: 9.61%10Y: 16.00%
ALGN - Gross Profit
14-Day FREE Trial Get Full Access Now!
ALGN Gross Profit CAGR:1Y: 3.56%2Y: 6.22%5Y: 8.11%10Y: 16.55%
ALGN - Expenses
14-Day FREE Trial Get Full Access Now!
ALGN Expenses CAGR:1Y: -31.28%2Y: -34.31%5Y: -11.61%10Y: 12.40%
ALGN - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
ALGN Shares Outstanding CAGR:1Y: -1.76%2Y: -2.09%5Y: -1.21%10Y: -0.94%
ALGN - Share Buybacks
14-Day FREE Trial Get Full Access Now!
ALGN Share Buybacks CAGR:1Y: -32.38%2Y: 12.60%5Y: 15.08%10Y: 25.57%
ALGN - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
ALGN Stock-Based Comp CAGR:1Y: 0.05%2Y: 5.83%5Y: 13.64%10Y: 14.00%
ALGN - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
ALGN Revenue CAGR:1Y: 4.02%2Y: 5.07%5Y: 8.90%10Y: 17.49%
ALGN - Revenue by Region
14-Day FREE Trial Get Full Access Now!
ALGN Revenue CAGR:1Y: 4.02%2Y: 5.07%5Y: 8.90%10Y: 17.49%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ALGN - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ALGN Actual Revenue CAGR:1Y: 4.02%2Y: 5.07%5Y: 8.90%10Y: 17.49%
ALGN - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ALGN Actual EPS CAGR:1Y: -15.24%2Y: 60.44%5Y: -1.90%10Y: 11.22%
ALGN - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ALGN Actual Net Income CAGR:1Y: -16.29%2Y: 57.64%5Y: -3.06%10Y: 10.13%
ALGN - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ALGN Actual EBITDA CAGR:1Y: -30.11%2Y: 3.12%5Y: -0.94%10Y: 9.94%

Ratios, Profit Margins & Return on Capital:

ALGN - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
ALGN Net Profit Margin CAGR:1Y: -19.52%2Y: 50.09%5Y: -10.98%10Y: -6.26%
ALGN - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
ALGN Gross Profit Margin CAGR:1Y: -0.44%2Y: 1.10%5Y: -0.73%10Y: -0.80%
ALGN - Price to Earnings
14-Day FREE Trial Get Full Access Now!
ALGN - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
ALGN - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
ALGN - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

Projected Future Returns & Dividends for ALGN

Based on past 10-year performance, here are ALGN growth metrics:

Share price CAGR of +11.56%
Dividend CAGR of +0%

Using ALGN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

ALGN (DRIP)ALGN - No DRIP
Current Price$176.74$176.74
Start Shares56.5856.58
Start Value$10,000$10,000
  
After 10 years:
Final Share Count56.5856.58
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$473.13$176.74
Total Dividends$0$0
Final Value$26,770$10,000

Estimated Future Value + Dividends - ALGN

NOTE: Above numbers are our estimate based on ALGN's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Align Technology, Inc. (ALGN) had its IPO on 2001-01-30, and is trader on NASDAQ stock exchange.

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

ALGN website: https://www.aligntech.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial